The eight Summit directors designated by Summit pursuant to the Merger Agreement and the Burke & Herbert bylaw amendment, each of whom previously served as a member of the board of directors of Summit and was appointed as a member of the Board, in each case effective as of the Effective Time (the “Summit Continuing Directors”), are as follows: Oscar M. Bean, James P. Geary, II, Georgette R. George, Gary L. Hinkle, Jason A. Kitzmiller, H. Charles Maddy, III, Charles S. Piccirillo, and Jill S. Upson.
On May 1, 2024, David T. Kollat notified the Board of Directors (the “Board”) of Wolverine World Wide, Inc. (the “Company”) of his intention to retire as a director of the Company effective upon the completion of his current term at the Company’s 2025 Annual Meeting of Shareholders.
On April 26, 2024, Ms. Sheri S. Cook, a member of the Board of Directors (the “Board”) of First US Bancshares, Inc. (the “Company”), notified the Company of her resignation as a director of the Company effective April 26, 2024.
On April 30, 2024, Itziar Canamasas, Ph.D., informed the Company of her resignation as a member of the Board and all committees thereof, effective immediately, due to her taking a new professional position that does not permit her to continue on as a director of the Company.
On April 28, 2024, Jack Nielsen informed ALX Oncology Holdings Inc. (the “Company”) of his resignation as a member of the Company’s Board of Directors (the “Board”) and all committees thereof, effective immediately, due to health reasons.
Departed
Rex S. Jackson
Director
EMCORE CORP
Effective
2024-04-29
Filed
May 2, 2024, 7:59 PM ET
On April 29, 2024, Rex S. Jackson resigned from the Company’s Board of Directors effective on April 29, 2024.
each of David S. Mulcahy, Anant Bhalla, Joyce A. Chapman, Brenda J. Cushing, Michael E. Hayes, Douglas T. Healy, Robert L. Howe, William R. Kunkel, Alan D. Matula and Gerard D. Neugent, being all of the directors of the Company immediately prior to the Effective Time, resigned and ceased to be directors of the Company.
each of David S. Mulcahy, Anant Bhalla, Joyce A. Chapman, Brenda J. Cushing, Michael E. Hayes, Douglas T. Healy, Robert L. Howe, William R. Kunkel, Alan D. Matula and Gerard D. Neugent, being all of the directors of the Company immediately prior to the Effective Time, resigned and ceased to be directors of the Company.
the directors of Merger Sub in office immediately prior to the consummation of the Merger, comprising of Sachin Shah, Jon Bayer, Anne Schaumburg and Gregory Morrison, became the directors of the Company
each of David S. Mulcahy, Anant Bhalla, Joyce A. Chapman, Brenda J. Cushing, Michael E. Hayes, Douglas T. Healy, Robert L. Howe, William R. Kunkel, Alan D. Matula and Gerard D. Neugent, being all of the directors of the Company immediately prior to the Effective Time, resigned and ceased to be directors of the Company.
each of David S. Mulcahy, Anant Bhalla, Joyce A. Chapman, Brenda J. Cushing, Michael E. Hayes, Douglas T. Healy, Robert L. Howe, William R. Kunkel, Alan D. Matula and Gerard D. Neugent, being all of the directors of the Company immediately prior to the Effective Time, resigned and ceased to be directors of the Company.
each of David S. Mulcahy, Anant Bhalla, Joyce A. Chapman, Brenda J. Cushing, Michael E. Hayes, Douglas T. Healy, Robert L. Howe, William R. Kunkel, Alan D. Matula and Gerard D. Neugent, being all of the directors of the Company immediately prior to the Effective Time, resigned and ceased to be directors of the Company.
the directors of Merger Sub in office immediately prior to the consummation of the Merger, comprising of Sachin Shah, Jon Bayer, Anne Schaumburg and Gregory Morrison, became the directors of the Company
each of David S. Mulcahy, Anant Bhalla, Joyce A. Chapman, Brenda J. Cushing, Michael E. Hayes, Douglas T. Healy, Robert L. Howe, William R. Kunkel, Alan D. Matula and Gerard D. Neugent, being all of the directors of the Company immediately prior to the Effective Time, resigned and ceased to be directors of the Company.
the directors of Merger Sub in office immediately prior to the consummation of the Merger, comprising of Sachin Shah, Jon Bayer, Anne Schaumburg and Gregory Morrison, became the directors of the Company
each of David S. Mulcahy, Anant Bhalla, Joyce A. Chapman, Brenda J. Cushing, Michael E. Hayes, Douglas T. Healy, Robert L. Howe, William R. Kunkel, Alan D. Matula and Gerard D. Neugent, being all of the directors of the Company immediately prior to the Effective Time, resigned and ceased to be directors of the Company.
each of David S. Mulcahy, Anant Bhalla, Joyce A. Chapman, Brenda J. Cushing, Michael E. Hayes, Douglas T. Healy, Robert L. Howe, William R. Kunkel, Alan D. Matula and Gerard D. Neugent, being all of the directors of the Company immediately prior to the Effective Time, resigned and ceased to be directors of the Company.
each of David S. Mulcahy, Anant Bhalla, Joyce A. Chapman, Brenda J. Cushing, Michael E. Hayes, Douglas T. Healy, Robert L. Howe, William R. Kunkel, Alan D. Matula and Gerard D. Neugent, being all of the directors of the Company immediately prior to the Effective Time, resigned and ceased to be directors of the Company.
each of David S. Mulcahy, Anant Bhalla, Joyce A. Chapman, Brenda J. Cushing, Michael E. Hayes, Douglas T. Healy, Robert L. Howe, William R. Kunkel, Alan D. Matula and Gerard D. Neugent, being all of the directors of the Company immediately prior to the Effective Time, resigned and ceased to be directors of the Company.
the directors of Merger Sub in office immediately prior to the consummation of the Merger, comprising of Sachin Shah, Jon Bayer, Anne Schaumburg and Gregory Morrison, became the directors of the Company
In addition, on April 26, 2024, Alan Cohen tendered his resignation from the board of directors of the Company, effective immediately.
Departed
David Proman
Director
APx Acquisition Corp. I
Effective
2024-03-08
Filed
May 2, 2024, 7:59 PM ET
On March 8, 2024, effective immediately, David Proman and Diego Dayenoff resigned as directors
Appointed
Daniel Mudd
Director
APx Acquisition Corp. I
Effective
2024-03-08
Filed
May 2, 2024, 7:59 PM ET
the Board appointed Daniel Mudd as a director
Departed
Diego Dayenoff
Director
APx Acquisition Corp. I
Effective
2024-03-08
Filed
May 2, 2024, 7:59 PM ET
On March 8, 2024, effective immediately, David Proman and Diego Dayenoff resigned as directors
Appointed
Fara Remtulla
director
APx Acquisition Corp. I
Effective
2024-04-06
Filed
May 2, 2024, 7:59 PM ET
Effective as of the same date, the Board appointed each of Thomas P.M. Barry and Fara Remtulla as a director of the Company and a member of the audit, compensation and nomination and governance committees of the Company’s board of directors.
Departed
Angel Losada Moreno
director
APx Acquisition Corp. I
Effective
2024-04-06
Filed
May 2, 2024, 7:59 PM ET
Effective April 6, 2024, Angel Losada Moreno resigned as a director of APX Acquisition Corp. I (the “Company”).
Appointed
Thomas P.M. Barry
director
APx Acquisition Corp. I
Effective
2024-04-06
Filed
May 2, 2024, 7:59 PM ET
Effective as of the same date, the Board appointed each of Thomas P.M. Barry and Fara Remtulla as a director of the Company and a member of the audit, compensation and nomination and governance committees of the Company’s board of directors.
On April 30, 2024, the Board of Directors (the “Board”) of Vor Biopharma Inc. (the “Company”) increased the size of the Board from six to seven members and appointed Fouad Namouni, M.D., to fill the resulting vacancy, to serve on the Board as an independent Class II director, until the Company’s 2026 annual meeting of stockholders and until his successor is duly elected and qualified.
Effective as of May 2, 2024, the Board approved an increase in the size of the Board from seven members to eight members and unanimously appointed Jeffrey J. Donnelly, the Company’s Chief Executive Officer, to fill the newly created vacancy.
Appointed
Darren Smith
Director
QSAM Biosciences, Inc.
Effective
2024-05-02
Filed
May 2, 2024, 7:59 PM ET
Kevin Richardson and Darren Smith became the directors of the surviving corporation.
Departed
Douglas R. Baum
Director
QSAM Biosciences, Inc.
Effective
2024-05-02
Filed
May 2, 2024, 7:59 PM ET
C. Richard Piazza, Douglas R. Baum, Charles J. Link, Jr., Adriann Sax, each resigned and ceased serving as directors.
Appointed
Kevin Richardson
Director
QSAM Biosciences, Inc.
Effective
2024-05-02
Filed
May 2, 2024, 7:59 PM ET
Kevin Richardson and Darren Smith became the directors of the surviving corporation.
Departed
Charles J. Link, Jr.
Director
QSAM Biosciences, Inc.
Effective
2024-05-02
Filed
May 2, 2024, 7:59 PM ET
C. Richard Piazza, Douglas R. Baum, Charles J. Link, Jr., Adriann Sax, each resigned and ceased serving as directors.
Departed
Adriann Sax
Director
QSAM Biosciences, Inc.
Effective
2024-05-02
Filed
May 2, 2024, 7:59 PM ET
C. Richard Piazza, Douglas R. Baum, Charles J. Link, Jr., Adriann Sax, each resigned and ceased serving as directors.
Departed
C. Richard Piazza
Director
QSAM Biosciences, Inc.
Effective
2024-05-02
Filed
May 2, 2024, 7:59 PM ET
C. Richard Piazza, Douglas R. Baum, Charles J. Link, Jr., Adriann Sax, each resigned and ceased serving as directors.
Departed
Jeffrey A. Coleman
director
Clearday, Inc.
Effective
2024-04-30
Filed
May 2, 2024, 7:59 PM ET
On April 30, 2024, Jeffrey A. Coleman tendered his resignation as a director of Clearday, Inc. (the “ Company ”).
On April 27, 2024, Barry McCarthy notified Peloton Interactive, Inc. (the “Company”) of his resignation from the Company’s Board of Directors (the “Board”) as a Class I director, effective April 28, 2024.
On April 30, 2024, Jason Kilar provided a written notice to Opendoor Technologies Inc. (the “Company”) of his intent to resign from the Board of Directors (the “Board”), and all committees thereof, as applicable, effective at the conclusion of the Company’s annual meeting of stockholders on June 14, 2024.
Departed
Dr. Jeffrey Russakow
Director
Getaround, Inc
Effective
2024-04-28
Filed
May 1, 2024, 7:59 PM ET
Effective as of April 28, 2024, Dr. Jeffrey Russakow, a member of the Board, resigned from the Board, including all committees thereof.
the Board of Directors of Phoenix Motor Inc. (the “Company”) increased the size of the Board of Directors from five members to seven members, and elected Kristine Chen and Steven Li as directors of the Company, effective immediately.
the Board of Directors of Phoenix Motor Inc. (the “Company”) increased the size of the Board of Directors from five members to seven members, and elected Kristine Chen and Steven Li as directors of the Company, effective immediately.
Appointed
Grant Moon
director
Moatable, Inc.
Effective
2024-04-30
Filed
May 1, 2024, 7:59 PM ET
On April 30, 2024, the Board appointed Grant Moon to serve as a director of the Company, effective as of April 30, 2024.
Departed
Rebecca Polak
director
Moatable, Inc.
Effective
2024-05-01
Filed
May 1, 2024, 7:59 PM ET
On April 29, 2024, the Company received notification from Rebecca Polak of her intention to resign as a member of the Board of the Company, effective May 1, 2024.
Departed
James Dumler
director
Moatable, Inc.
Effective
2024-05-01
Filed
May 1, 2024, 7:59 PM ET
On April 29, 2024, Moatable, Inc. (the “Company”) received notification from James Dumler of his intention to resign as a member of the Board of Directors (the “Board”) of the Company, effective May 1, 2024.
Recent executive movements from 8-K Item 5.02 filings, source-linked. Cards are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.